Does maternal body mass index influence treatment effect in women with mild gestational diabetes?

American Journal of Perinatology

Volumn 32, Issue 1, 2015, Pages 93-100

  Casey, Brian M ^a   Mele, Lisa ^b   Landon, Mark B ^c   Spong, Catherine Y ^d   Ramin, Susan M ^e   Wapner, Ronald J ^f   Varner, Michael W ^g   Rouse, Dwight J ^h   Thorp, John M ⁱ   Catalano, Patrick ^j   Harper, Margaret ^k   Saade, George ^l   Sorokin, Yoram ^m   Peaceman, Alan M ⁿ  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f Och Spine at New York Presbyterian Hospitals   (United States)

^g UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^j METROHEALTH MEDICAL CENTER   (United States)

^k WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^l University of Texas Medical Branch School of Medicine   (United States)

^m WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ NORTHWESTERN UNIVERSITY   (United States)

more..

Author keywords

BMI; gestational diabetes; treatment effect

Indexed keywords

ANTIDIABETIC AGENT; C PEPTIDE; INSULIN;

ADIPOSE TISSUE; ADULT; BLOOD; BLOOD GLUCOSE MONITORING; BODY MASS; CHEMISTRY; CONTROLLED STUDY; DIABETES, GESTATIONAL; DIET THERAPY; FEMALE; FETAL MACROSOMIA; FETUS BLOOD; HUMAN; OBESITY; PREGNANCY; PREGNANCY COMPLICATION; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

ADIPOSE TISSUE; ADULT; BLOOD GLUCOSE SELF-MONITORING; BODY MASS INDEX; C-PEPTIDE; DIABETES, GESTATIONAL; DIET THERAPY; FEMALE; FETAL BLOOD; FETAL MACROSOMIA; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; OBESITY; OVERWEIGHT; PREGNANCY; PREGNANCY COMPLICATIONS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84900352878     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0034-1374815     Document Type: Article

References (28)

1. Schaefer-Graf U. M., Heuer R., Kilavuz O., Pandura A., Henrich W., Vetter K. Maternal obesity not maternal glucose values correlates best with high rates of fetal macrosomia in pregnancies complicated by gestational diabetes. J Perinat Med: 2002; 30 4 313 321
2. Ehrenberg H. M., Mercer B. M., Catalano P. M. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol: 2004; 191 3 964 968
3. Schaefer-Graf U. M., Kjos S. L., Kilavuz O., et al. Determinants of fetal growth at different periods of pregnancies complicated by gestational diabetes mellitus or impaired glucose tolerance. Diabetes Care: 2003; 26 1 193 198
4. Voldner N., Qvigstad E., Froslie K. F., Godang K., Henriksen T., Bollerslev J. Increased risk of macrosomia among overweight women with high gestational rise in fasting glucose. J Matern Fetal Neonatal Med: 2010; 23 1 74 81
5. HAPO Study Cooperative Research Group Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: associations with maternal body mass index. BJOG: 2010; 117 5 575 584
6. Durnwald C., Huston-Presley L., Amini S., Catalano P. Evaluation of body composition of large-for-gestational-age infants of women with gestational diabetes mellitus compared with women with normal glucose tolerance levels. Am J Obstet Gynecol: 2004; 191 3 804 808
7. Metzger B. E., Lowe L. P., Dyer A. R., et al. HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med: 2008; 358 19 1991 2002
8. Hull H. R., Dinger M. K., Knehans A. W., Thompson D. M., Fields D. A. Impact of maternal body mass index on neonate birthweight and body composition. Am J Obstet Gynecol: 2008; 198 4 e1 e6
9. Sewell M. F., Huston-Presley L., Super D. M., Catalano P. Increased neonatal fat mass, not lean body mass, is associated with maternal obesity. Am J Obstet Gynecol: 2006; 195 4 1100 1103
10. García-Patterson A., Aulinas A., María M. A., et al. Maternal body mass index is a predictor of neonatal hypoglycemia in gestational diabetes mellitus. J Clin Endocrinol Metab: 2012; 97 5 1623 1628
11. Coustan D. R., Lowe L. P., Metzger B. E., Dyer A. R.; International Association of Diabetes and Pregnancy Study Groups. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitus. Am J Obstet Gynecol: 2010; 202 6 e1 e6
12. Crowther C. A., Hiller J. E., Moss J. R., McPhee A. J., Jeffries W. S., Robinson J. S.; Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med: 2005; 352 24 2477 2486
13. Landon M. B., Spong C. Y., Thom E., et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med: 2009; 361 14 1339 1348
14. Hadar E., Hod M. Establishing consensus criteria for the diagnosis of diabetes in pregnancy following the HAPO study. Ann N Y Acad Sci: 2010; 1205 88 93
15. Metzger B. E., Coustan D. R.; The Organizing Committee. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care: 1998; 21 02 B161 B167
16. Alexander G. R., Kogan M. D., Himes J. H. 1994-1996 U.S. singleton birth weight percentiles for gestational age by race, Hispanic origin, and gender. Matern Child Health J: 1999; 3 4 225 231
17. Catalano P. M., Thomas A. J., Avallone D. A., Amini S. B. Anthropometric estimation of neonatal body composition. Am J Obstet Gynecol: 1995; 173 4 1176 1181
18. Catalano P. M. Management of obesity in pregnancy. Obstet Gynecol: 2007; 109 2 Pt 1 419 433
19. Spellacy W. N., Miller S., Winegar A., Peterson P. Q. Macrosomia-maternal characteristics and infant complications. Obstet Gynecol: 1985; 66 2 158 161
20. Lucas M. J., Lowe T. W., Bowe L., McIntire D. D. Class A1 gestational diabetes: a meaningful diagnosis? Obstet Gynecol: 1993; 82 2 260 265
21. Catalano P. M., Drago N. M., Amini S. B. Factors affecting fetal growth and body composition. Am J Obstet Gynecol: 1995; 172 5 1459 1463
22. Catalano P. M., Hauguel-De Mouzon S. Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol: 2011; 204 6 479 487
23. Brody S. C., Harris R., Lohr K. Screening for gestational diabetes: a summary of the evidence for the U.S. Preventive Services Task Force. Obstet Gynecol: 2003; 101 2 380 392
24. Jansson T., Cetin I., Powell T. L., et al. Placental transport and metabolism in fetal overgrowth - a workshop report. Placenta: 2006; 27 (Suppl A): S109 S113
25. Radaelli T., Lepercq J., Varastehpour A., Basu S., Catalano P. M., Hauguel-De Mouzon S. Differential regulation of genes for fetoplacental lipid pathways in pregnancy with gestational and type 1 diabetes mellitus. Am J Obstet Gynecol: 2009; 201 2 e1, e10
26. Getahun D., Ananth C. V., Peltier M. R., Salihu H. M., Scorza W. E. Changes in prepregnancy body mass index between the first and second pregnancies and risk of large-for-gestational-age birth. Am J Obstet Gynecol: 2007; 196 6 e1 e8
27. Metzger B. E., Buchanan T. A., Coustan D. R., et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care: 2007; 30 02 S251 S260
28. Abrams B. F., Laros R. K. Jr. Prepregnancy weight, weight gain, and birth weight. Am J Obstet Gynecol: 1986; 154 3 503 509